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Introduction
Because of the increasing use of ultrasonography (US) for
fetal-maternal screening, the number of fetuses identified
with hydronephrosis has increased markedly. The
appropriate prenatal care of the fetus diagnosed with
such a condition, and the postnatal evaluation and
treatment, are not always evident. Guidelines for the
evaluation of this finding are outlined in the present
review.
Incidence
The overall incidence of genitourinary abnormalities
during routine prenatal US screening is 2–9 per 1000
births [1–5], with a male to female ratio of 2 : 1 [3]. The
spectrum of genitourinary abnormalities detected in utero
is extremely varied; most affected fetuses (50–87%) have
hydronephrosis [6–8]. The remaining anomalies include
multicystic dysplastic kidney, autosomal recessive poly-
cystic kidney disease, renal agenesis and dysplasia. Other
abnormalities that have been described include bladder
exstrophy, adrenal hyperplasia, imperforate anus, cloacal
abnormalities, neuroblastoma, mesoblastic nephroma
and genital abnormalities [6].
The accuracy of the prenatal diagnosis of hydrone-
phrosis has been compared with postnatal evaluations
and a false-positive diagnostic error rate of 9–22% is
reported [9,10]. This overestimation may be because
there are no accepted criteria for the diagnosis of
hydronephrosis, and in utero resolution during fetal
development [11].
Natural history
Antenatal hydronephrosis is mostly a physiological state
which will resolve either before the end of pregnancy
or within the first year of life. An explanation for
spontaneous resolution of hydronephrosis is the tran-
sitional (antenatal to postnatal) renal physiology and
histology/anatomy of the developing ureter. Fetal urine
flow is 4–6 times greater before than after delivery
because of differences in renovascular resistance, GFR
and concentrating ability. This high outflow might
contribute to ureteric dilatation in the absence of
functionally significant obstruction, as is occasionally
seen with diabetes insipidus [12]. Another contributing
factor is the increased compliance of the fetal ureter.
Increased compliance has been implicated in the tortuous
dilatations seen with distal obstructions in the newborn,
which contrast with the ‘pipe stem’ of later life. These
changes may result from differences in the deposition and
orientation of elastin, collagen and other matrices, which
occur at various rates in the developing fetal ureter [13].
Finally, partial or transient anatomical or functional
obstructions that spontaneously improve with postnatal
development could contribute to proximal dilatation.
Persistent fetal ureteric folds or delays in the development
of normal peristalsis may represent such transient
obstructions [12].
Most antenatal hydronephrosis that is confirmed
postnatally, even with bilateral involvement, is mild or
moderate as a consequence of partial obstruction during
embryological development. The natural history of mild
and moderate degrees of partial ureteric obstruction
has been studied in neonatal rats. Josephson et al. [14]
created mild to moderate partial obstruction and
observed a decrease in renal blood flow (RBF), GFR and
potassium excretion that approached 30%, and was
largely compensated by an increase in the contralateral
kidney. The obstruction in the experimental model must
be relieved early to reverse the loss of glomerular
function.
The upper urinary tract in prenatally detected hydro-
nephrosis is rarely completely obstructed. Such rare cases
will result in a nonfunctioning kidney with severe cystic
dysplasia of the nephrogenic tissue [7]. The outcome of
these lesions is related to the occurrence of nonrenal
congenital anomalies, which is much higher in those
infants who ultimately die in the perinatal period. The
strongest indicators of a poor prognosis in such cases
include early onset of severe renal parenchymal changes,
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oligohydramnios, severe nonrenal congenital anomalies
and bladder outlet obstruction [11]. When severe
obstruction is produced experimentally, there is a rapid
and progressive 80–90% decrease in RBF and GFR,
which may not be recoverable [15,16]. Tubular function,
such as potassium and phosphate excretion, is also
significantly decreased. Experimentally, when obstruc-
tion in the neonatal period was sufficient to lead to a
measured decrease in renal function, some of this was not
recoverable by relieving the obstruction, whereas similar
obstruction in the mature kidney produced reversible
changes [16]. With complete unilateral ureteric obstruc-
tion (UUO) in neonatal rats, Chevalier et al. [17] recently
showed that growth of the developing kidney decreased
linearly with the duration of ureteric obstruction.
Adaptive growth of the intact kidney exactly counter-
balances the decreased growth rate of the obstructed
kidney. These results suggest that to optimally preserve
renal mass in the developing kidney with complete
UUO, the obstruction should be relieved as soon as
possible.
Prenatal evaluation
The ability of prenatal US to detect fetal urinary tract
abnormalities is widely appreciated. Despite its wide
application, its continued use as a screening procedure is
still debated [18]. However, there may be specific
historical information or maternal physical findings
that may prompt the use of US for maternal-fetal
monitoring. Known genetic or familial abnormalities,
e.g. polycystic kidney disease or renal agenesis, could be
one such indication [11]. Abnormal uterine fundal
height for expected gestational age may be related to
fetal genitourinary abnormalities. Polyhydramnios can
be associated with unilateral hydronephrosis [19] and
oligohydramnios can be caused by renal dysgenesis/
agenesis or severe urinary tract obstruction [20].
Elevated maternal AFP has also been associated with
fetal uropathies [21].
When characterizing hydronephrosis detected in utero,
the degree of dilatation must be correlated with the age of
gestation at diagnosis, because it has been shown to vary
during gestation. Several studies have evaluated the
threshold of fetal hydronephrosis resulting in clinically
significant neonatal disease [6,11,22]. In most, there
are persistent postnatal renal abnormalities when
the anteroposterior diameter (APD) of the fetal
renal pelvis measures >6 mm at <20 weeks,>8 mm
at 20–30 weeks and >10 mm at >30 weeks of
gestation.
The degree of antenatal hydronephrosis after week 20
of gestation has been divided into five grades by Grignon
et al. [23]:
’ grade I, the pelvic APD is 1 cm with normal calyces
’ grade II, APD 1–1.5 cm with normal calyces
’ grade III, APD>1.5 cm with slight caliectasis
’ grade IV, APD>1.5 cm with moderate caliectasis
’ grade V, APD>1.5 cm with severe caliectasis and
cortical atrophy
A simpler classification is:
’ mild hydronephrosis with pelvic APD f1.5 cm and
normal calyces
’ moderate hydronephrosis with APD>1.5 cm and
caliectasis with no parenchymal atrophy
’ severe hydronephrosis with APD>1.5 cm, caliectasis
and cortical atrophy [8].
Diagnostic categories
It is important to characterize fetal hydronephrosis by
its severity, laterality and its association with ureteric
dilatation, renal parenchymal changes, and abnormal-
ities of bladder size, thickness and emptying. The
presence of concomitant oligohydramnios is important
in determining the prognosis.
PUJ obstruction is by far the most common cause of
antenatal hydronephrosis and is characterized by vary-
ing degrees of fetal renal pelvic dilatation, caliectasis, no
visible ipsilateral ureter, normal bladder and normal
amniotic fluid volume. When ureteric dilatation occurs
with pelvicalyceal dilatation, the most common postnatal
abnormalities found are VUR, megaureter, PUV, prune-
belly syndrome and ureteric ectopia. Because ureteric
dilatation is often not seen, many cases of generic
hydronephrosis may be caused by VUR or megaureter.
The postnatal diagnosis of reflux is reported in 25–35% of
fetuses with nonspecific hydronephrosis [24–26]. The
presence of significant hydroureteronephrosis, a large
thin-walled bladder, and normal renal architecture and
amniotic fluid volume in a male fetus most probably
signifies massive reflux, which has been termed mega-
cystis-megaureter association [11,27]. Duplication
anomalies should be suspected when there is asymmetric
dilatation of the ipsilateral upper collecting systems, or a
ureterocele can be seen in the bladder. In many such
cases the diagnosis is not made until after birth [28].
PUV in a male fetus is characterized by uni- or bilateral
hydroureteronephrosis, a thick-walled, trabeculated and
sometimes enlarged bladder, a dilated posterior urethra,
renal parenchymal change, such as hyperechogenicity or
(subcortical) cysts, and varying degrees of oligohydram-
nios. PUV may be confused with prune-belly syndrome,
characterized by ureteric dilatation that is proportionally
greater than expected for renal pelvic diameter, an
enlarged bladder with evidence of a urachal abnormality,
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and the presence of a megalourethra. In most cases, the
amniotic fluid volume is normal [11].
Fetal intervention
Once a fetal genitourinary abnormality is diagnosed, the
management of the fetus is controversial. In most cases, if
the diagnosis is made in the second trimester, additional
US is carried out closer to term. In bilateral hydrour-
eteronephrosis and an enlarged bladder, US is recom-
mended every 4 weeks after the initial diagnosis. Other
more invasive diagnostic procedures to assess the overall
status of the fetus include amniocentesis, per umbilical
blood sampling (PUBS), and chorionic villous sampling.
PUBS has become a standard method for rapid fetal
sampling as early as 14–16 weeks of gestation, whereas
chorionic villous sampling has the advantage of allowing
chromosomal analysis at 8–10 weeks [11].
The ability to analyse renal function and predict future
renal reserve remains a difficult dilemma. The US finding
of hyperechogenic fetal kidneys was a nonspecific marker
for postnatal renal US or functional abnormalities [29].
The use of fetal bladder aspiration, and observation of
refilling and examination of fetal urine is the most helpful
guide to potential functional reserve. Numerous urinary
electrolytes and proteins have been suggested as markers
to predict the presence of severe renal injury in fetuses
with obstructive uropathy, but without complete success.
Of these, the most useful are albumin, B2-microglobulin,
sodium, chloride and osmolality. Prognostic features
for good renal function include fetal urinary sodium
<100 mmol/L, chloride of <90 mmol/L, and an
osmolality of <210 mOsm/kg. Vates et al. [30] evaluated
the use of urinary EGF as a predictive marker of such
injury. They found that fetuses with a good outcome had
a trend toward higher EGF levels (mean 19.1 ng/mL) in
later gestation, compared with a decline (mean 6.5 ng/
mL) in those with a poor outcome.
Elective termination of pregnancy is available up to
about 23 weeks of gestation. Most major system defects
can be detected if the gestational US is performed at
16–20 weeks. If severe abnormalities are detected then
this option should be presented [11].
Prenatal intervention is indicated in a minority of cases
of prenatally detected hydronephrosis. In such cases,
there should be intervention only at an experienced
institution under approved protocols [7]. The clinical
setting in which fetal intervention involving chronic
bladder drainage appears to be most appropriate is the
male fetus in the second trimester who presents with
severe bilateral hydroureteronephrosis, reasonable fetal
urinary indicators, and progressive oligohydramnios.
The rationale for fetal urinary drainage is that with
severe early obstruction both renal and pulmonary
development are impaired. Theoretically, bypassing the
obstructed urinary system by shunting urine directly into
the amniotic cavity will decompress the kidneys enough
to prevent irreversible damage and prevent the develop-
ment of pulmonary hypoplasia associated with oligohy-
dramnios [11]. Successful percutaneous ureterostomy
and vesicostomy has been recorded in a few patients [31];
no data are available from larger series on the outcome of
kidney function after intrauterine intervention. However,
complications such as obstruction or displacement of the
shunt and bowel herniation along the needle tract have
been reported. Moreover, fetal intervention may carry the
risks of fetal injury, maternal infection, induction of early
labour, miscarriage, risk to subsequent pregnancies, and
inappropriate interventions for conditions that are not
life-threatening.
Postnatal management
The initial assessment of a neonate with prenatally
identified hydronephrosis will consist of confirmatory
postnatal US usually 2–3 days after delivery, depending
on the antenatal severity of dilatation and probable
diagnosis. Unless hydroureteronephrosis is bilateral or a
serious urological abnormality (e.g. PUV or obstruction
of a solitary kidney) is suspected, further diagnostic
evaluation can be deferred until one month of life. Well-
documented cases of pathology have been missed when
US is used during the first few days of life because
neonatal oliguria can mask a moderately obstructed
lesion [32].
The importance of prophylactic antibiotics in infants
with prenatally detected hydronephrosis that is con-
firmed postnatally has not been formally tested. Although
it is expected that an infection with ureteric obstruction
can cause significant renal damage, there are no
published data available to suggest that antibiotic
prophylaxis has a better outcome. Therefore, some
authors recommend prophylactic antibiotics to all infants
with prenatally detected hydronephrosis that is
confirmed postnatally, while other institutions only
administer antibiotics when the dilatation is severe
(e.g.>10 mm renal pelvis). Oral penicillin G (20 kIU/
kg), oral amoxicillin (15 mg/kg) or trimethoprim (2 mg/
kg) once a day are commonly used.
When the initial evaluation reveals bilateral hydro-
nephrosis or unilateral hydronephrosis in a single
functioning kidney, immediate US and VCUG are
performed. If PUV is confirmed, then a resection or
drainage is instituted. If VUR or an (obstructive)
megaureter is found, then antibiotic prophylaxis is
begun. When hydronephrosis is unilateral, or if
bilateral and less marked, a diagnostic algorithm is
used (Fig. 1).
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Postnatal diagnosis of obstruction
It took more than half a century for urologists to
recognize that hydronephrosis is not necessarily equiva-
lent to obstruction. Several studies showed that many
neonatal kidneys with severe hydronephrosis are not
biologically obstructed despite even a profound initial
decrease in renal function. Further follow-up of these
kidneys showed no deterioration of renal function, no













US –  DR every
3–6 months
Manage VUR DR at 1 month
VCUG at
1 month No dilatationHydronephrosis
Prophylactic
antibiotics US at 1 month
Hydronephrosis No dilatation
US 2 days after birth
Unilateral antenatal hydronephrosis
Fig. 1. An algorithm for neonatal
evaluation of unilateral or mild bilateral
hydronephrosis. US, ultrasonography; DR,
diuretic renogram.
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contralateral compensatory renal hypertrophy. On the
other hand, misdiagnosis of a truly obstructed kidney
results in a serious deterioration of renal function that
may be irreversible. Therefore, a continuing debate in the
management of neonatal hydronephrosis is concerned
with the definition of when significant obstruction is
present. All of the standard diagnostic tests for assessing
hydronephrosis in this age group, e.g. IVU, US, renogram
and the Whitaker test, are inaccurate. The diagnosis in
most cases is only possible by repeated investigations and
changes of the variables during a longer follow-up.
IVU and US
In the neonate, reliance on the morphological appear-
ance of a dilated renal pelvis from initial IVU or US is
insufficient to diagnose obstruction. However, the detec-
tion of progressive hydronephrosis on further sequential
studies could be an indicator of the presence of
obstruction. Koff et al. [33] used US to measure the size
of the normal kidney opposite a unilateral hydrone-
phrotic kidney in infants, to determine if compensatory
changes occurred and could be used as a diagnostic test
for defining or excluding obstruction. They showed that
normal kidneys opposite obstructed hydronephrotic
kidneys become larger than normal for age. They
suggested that by plotting serial measurements of
normal renal length on a renal growth chart, the
diagnosis of obstruction in newborn hydronephrosis can
be facilitated and the clinical management of the patient
improved. This view is supported by the recent experi-
mental work of Chevalier et al. [17] who showed an
exquisite sensitivity of renal counterbalance in complete
UUO in the developing kidney of neonatal rats.
The potential usefulness of the resistive index (RI)
obtained during Doppler ultrasonography (DUS) was
described by Platt et al. in 1989 [34]. The noninvasive
nature of the measurement of renal RI gives it
considerable appeal in its potential application in
children with obstructive uropathy. Although an RI of
0.70 is accepted by most investigators as an upper level of
normal in the adult population, more work is needed to
establish accepted standards of normal and abnormal for
the paediatric renal RI. It has been shown that the RI is
age-dependent, particularly in infants, and it is com-
monly >0.70 in healthy children in the first year of life
[35,36]. A normal RI in this setting should be valuable,
arguing against obstruction in the presence of a dilated
collecting system. We have shown that infusion of
normal saline and administration of frusemide signifi-
cantly increased the accuracy of the RI in the diagnosis
of obstructed kidneys in children [37,38]. The RI is
considered as a noninvasive method for monitoring the
dilated collecting system under observation.
Diuretic renogram
The post-frusemide drainage curve and the half-time
drainage (T1/2) are subject to so many variables that
they are unacceptable as indicators of the presence of
obstruction. The state of hydration, renal function,
volume and contractility of the renal pelvis, patient
position, bladder filling, timing and dose of diuretic
administration and the type of radiopharmaceutical may
all result in misinterpretation. Measurement of individual
renal function with demarcation of a decrease in function
has been adopted to determine the presence of obstruc-
tion. The critical value of individual renal function below
which obstruction is considered varied among different
studies. Values of <30% [39],<35% [40], or<40%
[41,42] have been suggested (normal = 50t5%).
Having adopted this principle, the changes of transitional
nephrology during the first weeks of life must be
considered. It is well known that renal function improves
rapidly in infancy, that the fastest rate of increase in GFR
occurs within the first 12 weeks of life and that this rate of
increase is inversely proportional to age [43]. The
younger the patient, the more rapidly renal function
improves as the kidney matures and ultimately attains
adult levels of renal function. This age-related effect of
renal maturation on improvement in renal function
should not be misinterpreted as a true improvement in
GFR after the surgical repair of suspected obstruction.
Failure of expected improvement in renal function on
further sequential radionuclide studies could be an
indicator of the presence of obstruction.
One way to improve the quality of the diuretic
renogram is to carry out the study under conditions of
maximal diuresis. After an oral water load of 20 mL/kg
body weight, hypotonic saline (NaCl 0.45% with glucose
2.5%) is administered intravenously over a 2-h period in
a dose of 2 L/1.73 m2 body surface. Especially in cases of
PUJ obstruction this seems to add significantly to the
specificity and sensitivity of the test [44].
The extraction factor (EF) is a component of the
radionuclide renal scan that has been used by some
investigators as a means of gauging clinically significant
obstruction. The EF measures the percentage uptake of
radionuclide by the kidneys 2–3 min after injection. The
normal mean EF in the newborn is 1.5% by each kidney,
with an increase to 2.5% occurring by the end of the first
year of life. The correlation coefficient of the EF with GFR
is < 0.92. If renal function is normal by EF and/or equal
to the contralateral undilated renal unit, the dilatation
seen does not represent a functionally significant
obstructive uropathy. Nevertheless, at present the EF
cannot be considered an ideal test, as it is not without
drawbacks. There is a variability of < 10% between the
EF and GFR. Moreover, the values for percentage
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function between ages 1 and 2 years have been defined
incompletely. Finally, the EF of the solitary kidney has
not been determined completely but it appears to be < 5%
[12].
The Whitaker test
Because it is invasive and has potential sources of error,
the Whitaker test is currently rarely used in the diagnosis
of infants with suspected obstruction. When an obstruc-
tion is present, the intrapelvic pressure will not increase
until after the collecting system is filled completely. Thus,
the potential for recording a falsely low pressure exists if
there is leakage of fluid outside the collecting system or if
the study is terminated before the pelvicalyceal system is
filled completely. Another source of error is the intrinsic
urine output of the kidney, as it contributes an unknown
volume to the total amount of fluid being perfused; the
potential for false-positive results should be considered
particularly in neonates, as the urine output of the kidney
being studied is high.
VCUG
There has been some controversy over which neonates
with a diagnosis of in utero hydronephrosis should
undergo VCUG. A common practice is that if the fetal
renal pelvic diameter is >8 mm, and caliectasis or
ureterectasis is present, then a VCUG is recommended.
Other investigators perform VCUG even if postnatal US
shows apparent resolution of the fetal hydronephrosis
[45]. A more difficult question is whether to perform
VCUG on all infants with any degree of pelvic dilatation
[26]. Hollowell et al. [46] reported a coexistence of
PUJ obstruction and VUR in 17 (14%) of 147 consecutive
patients undergoing pyeloplasty. Therefore, they recom-
mended that VCUG be part of the routine evaluation of
children with suspected PUJ obstruction.
Postnatal treatment
PUJ obstruction
The therapeutic management strategies for neonates
with such a condition is currently more diverse than
ever. Several published series have enthusiastically
supported immediate pyeloplasty [47–49]. The rationale
underlying this approach is that when obstruction in the
neonatal period led to a measured decrease in renal
function, some of this was not recoverable by relieving
the obstruction. However, in this approach the authors
were criticised for having largely relied on drainage
curves after frusemide or on IVU to conclude that the
systems were irreversibly obstructed. Moreover, it was
not known whether the improvement in renal function
shown by follow-up renography was caused by early
pyeloplasty or to the natural increase in renal function in
early postnatal life.
In 1985 there was a major change in the policy
outlining the management of antenatally detected
PUJ obstruction, after the report of Ransley and
Manzoni [41]. They assumed that a decrease in renal
function determines the presence of an obstruction that
requires surgical intervention. The philosophy under-
lying this approach is that in the presence of significant
obstruction, the filtration of a kidney will ultimately be
affected and conversely, in the absence of continuing
obstruction, function will remain stable indefinitely.
Reports since 1985 emphasize that kidneys can be
safely observed if the renal function is initially >35%
[42,43,50–52]. Nevertheless, what remains unknown is
the extent of functional damage caused if the kidney
requires a delayed pyeloplasty after a trial of conservative
management. There are no clear criteria that can predict
early which kidney will eventually require surgical
intervention. The follow-up studies by Ransley et al.
[42] showed that some mature kidneys did not
completely recover their lost function after pyeloplasty.
This may reflect a possible delay in relieving the
PUJ obstruction once the functional change is estab-
lished. This view was supported by Subramaniam et al.
[53], who recently showed that kidneys treated by
delayed pyeloplasty had less improvement in renal
function than those treated by early pyeloplasty.
Nevertheless, all studies investigating the role of early
surgery are retrospective. Recognition of prospective
factors that would justify a selective prophylactic
operation is currently without foundation. Some recent
reports have suggested that kidneys with a pelvic APD of
>2 cm should possibly be treated by surgery initially,
irrespective of renal function [53,54]. Whether early
pyeloplasty will ultimately be of greater benefit can only
be determined by a controlled randomized study.
Primary obstructive megaureter
In this case, impressive dilatation of the distal ureter has
not been associated with any detectable loss of renal
function and when followed serially the dilatation
resolves significantly. Of 34 renal units associated with
primary obstructive megaureter detected by prenatal US,
only two (6%) required an operation for diminishing
renal function and most showed decreased dilatation on
sequential development [12]. Therefore, surgery in the
absence of symptoms is recommended only when the
relative renal function is decreased (<35%) [7].
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Other causes
When a ureterocele is present, the best initial treatment is
endoscopic incision. With the diagnosis of an obstructed
ectopic ureter there are several options, depending upon
the degree of function in the associated renal unit, size of
the ureter and presence of VUR. When hydronephrosis is
related to a neurogenic bladder or the prune-belly
syndrome it is necessary to establish that bladder
emptying is adequate and usually surgery is not required.
When VUR is present antibiotic prophylaxis is the initial
management, while multicystic kidneys do not benefit
from antibiotic prophylaxis and are followed by serial US
[7]. Management of these other causes of hydronephrosis
is discussed in detail elsewhere.
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